IMR Agency
Title Detail
View:   Synopsis     Table of Contents     Territory     Found In

Evidence-based Management of Diabetes
by Jiten Vora, John B
Evidence-based Management
Paperback Book (502 Pages)
October 2012
The clinical management of patients with diabetes is rapidly evolving. Evidence-based Management of Diabetes provides a succinct summary of a range of topics, including areas where there is already well developed evidence for a particular treatment, but also those areas where the evidence is perhaps doubtful or there is some associated controversy or ambiguity. Where possible throughout the book treatment recommendations are given based on the available evidence and practice guidelines. The book also highlights the gaps in evidence where further research is needed. In the practice of diabetes care, there are many issues influencing practitoners currently. This book addresses many of the most pertinent issues concerning delivery of diabetes care such as:

Is diabetes preventable in high-risk individuals?
Once diabetes has developed what are the goals of treatment and how aggressive should treatment be whilst avoiding adverse effects?
What is the role of treating glycaemia in reducing macrovascular disease?
Who to screen, how to screen and who to treat for coronary artery disease?
Who and how to treat hyperglycaemia in acute coronary syndromes?
Has there been any progress in the management of gestational diabetes?
Is there an evidence base for the treatment of Type 2 diabetes with oral hypoglycaemic agents?

The authors are internationally renowned experts in the field of diabetes care who successfully and succinctly present state-of-the-art reviews based on the medical evidence designed to help the clinician be as best informed as possible in the care of patients with diabetes.
Chapter 1 Insulin resistance
Chapter 2 Goals of treatment
Chapter 3 Prevention of diabetes in high-risk individuals
Chapter 4 Early insulin initiation in type 2 diabetes
Chapter 5 Treatment of blood pressure
Chapter 6 Glucose control and macrovascular disease/morbidity
Chapter 7 Dual blockade of RAS in diabetes with ACE inhibitors and ARBs
Chapter 8 Anaemia and renal disease
Chapter 9 Treatment of foot conditions
Chapter 10 Coronary artery disease: who to screen, how to screen, when to treat
Chapter 11 Hyperglycaemia in patients with acute coronary syndromes
Chapter 12 Gestational diabetes
Chapter 13 Patient education
Chapter 14 Drugs and outcomes
Chapter 15 The role of CGMS in the management of type 1 and 2 diabetes
Chapter 16 Retinopathy treatment
Chapter 17 Neuropathy
This title is available for license in the following territories:

  • Worldwide
This title is can be found in the following categories: